HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peng Zhao Selected Research

Bu-Fei-Yi-Shen

11/2021Effective-component compatibility of Bufei Yishen formula protects COPD rats against PM2.5-induced oxidative stress via miR-155/FOXO3a pathway.
11/2021[Compatibility characteristics of Bufei Yishen formula III in regulating chronic obstructive pulmonary disease mucus hypersecretion].
11/2021Effective-components combination improves airway remodeling in COPD rats by suppressing M2 macrophage polarization via the inhibition of mTORC2 activity.
3/2021A chinese herbal formula ameliorates COPD by inhibiting the inflammatory response via downregulation of p65, JNK, and p38.
1/2021Identification of Potential Key Genes in the Pathogenesis of Chronic Obstructive Pulmonary Disease Through Bioinformatics Analysis.
7/2020Effective-component compatibility of Bufei Yishen formula II inhibits mucus hypersecretion of chronic obstructive pulmonary disease rats by regulating EGFR/PI3K/mTOR signaling.
7/2020Effective-constituent compatibility-based analysis of Bufei Yishen formula, a traditional herbal compound as an effective treatment for chronic obstructive pulmonary disease.
1/2020Bufei Yishen Formula Restores Th17/Treg Balance and Attenuates Chronic Obstructive Pulmonary Disease via Activation of the Adenosine 2a Receptor.
5/2018Restoring Th17/Treg balance via modulation of STAT3 and STAT5 activation contributes to the amelioration of chronic obstructive pulmonary disease by Bufei Yishen formula.
1/2018Integration of transcriptomics, proteomics, metabolomics and systems pharmacology data to reveal the therapeutic mechanism underlying Chinese herbal Bufei Yishen formula for the treatment of chronic obstructive pulmonary disease.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peng Zhao Research Topics

Disease

188Neoplasms (Cancer)
07/2022 - 06/2000
46Inflammation (Inflammations)
10/2022 - 11/2008
42Infections
12/2022 - 03/2006
39Glioma (Gliomas)
01/2022 - 12/2005
30Neoplasm Metastasis (Metastasis)
10/2022 - 05/2005
25Chronic Obstructive Pulmonary Disease (COPD)
05/2022 - 02/2014
23Pain (Aches)
12/2021 - 08/2006
23Hepatocellular Carcinoma (Hepatoma)
11/2021 - 06/2000
21Carcinogenesis
05/2022 - 06/2005
19Hypoxia (Hypoxemia)
05/2022 - 06/2002
19Breast Neoplasms (Breast Cancer)
01/2022 - 01/2009
18Lung Neoplasms (Lung Cancer)
01/2022 - 09/2006
17Stomach Neoplasms (Stomach Cancer)
03/2022 - 06/2009
16Glioblastoma (Glioblastoma Multiforme)
01/2022 - 12/2005
15Colorectal Neoplasms (Colorectal Cancer)
10/2022 - 05/2005
13Pituitary Neoplasms (Pituitary Adenoma)
05/2022 - 09/2017
13Fibrosis (Cirrhosis)
11/2021 - 11/2008
13Brain Ischemia (Cerebral Ischemia)
01/2021 - 01/2002
13Carcinoma (Carcinomatosis)
02/2016 - 06/2000
12Wounds and Injuries (Trauma)
10/2022 - 01/2006
11COVID-19
11/2021 - 01/2020
11Bacterial Infections (Bacterial Infection)
11/2021 - 09/2014
11Ischemia
08/2020 - 01/2004
10Neuralgia (Stump Neuralgia)
01/2021 - 08/2006
9Prostatic Neoplasms (Prostate Cancer)
06/2022 - 08/2007
9Body Weight (Weight, Body)
01/2022 - 11/2008
9Insulin Resistance
01/2022 - 03/2009
9Spinal Cord Injuries (Spinal Cord Injury)
11/2021 - 08/2006
9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 08/2011
8Pulmonary Fibrosis (Fibrosing Alveolitis)
07/2022 - 01/2017
8Reperfusion Injury
05/2022 - 01/2004
8Parkinson Disease (Parkinson's Disease)
01/2022 - 06/2012
8Disease Progression
10/2021 - 01/2014
8Stroke (Strokes)
01/2021 - 03/2008
8Marek Disease (Marek's Disease)
08/2018 - 01/2013
7Myocardial Infarction
06/2022 - 03/2005
7Obesity
01/2022 - 04/2010
7Liver Neoplasms (Liver Cancer)
01/2021 - 09/2011
7Colonic Neoplasms (Colon Cancer)
01/2021 - 11/2014
7Viremia
11/2017 - 11/2013
7Influenza in Birds (Avian Flu)
11/2017 - 01/2012
6Pneumonia (Pneumonitis)
12/2022 - 09/2014
6Hemorrhage
01/2022 - 09/2014
6Liver Cirrhosis (Hepatic Cirrhosis)
10/2021 - 01/2009
6Lymphatic Metastasis
01/2021 - 05/2003

Drug/Important Bio-Agent (IBA)

77Proteins (Proteins, Gene)FDA Link
10/2022 - 06/2005
38Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2009
32Pharmaceutical PreparationsIBA
07/2022 - 01/2009
29Messenger RNA (mRNA)IBA
06/2022 - 01/2004
27CytokinesIBA
11/2021 - 08/2007
25MicroRNAs (MicroRNA)IBA
03/2022 - 10/2008
24VaccinesIBA
01/2021 - 03/2010
18Small Interfering RNA (siRNA)IBA
04/2022 - 12/2005
17Biological ProductsIBA
10/2022 - 08/2012
16Long Noncoding RNAIBA
05/2022 - 01/2017
16EnzymesIBA
01/2022 - 07/2010
15Therapeutic UsesIBA
05/2022 - 05/2003
15AntibodiesIBA
03/2022 - 01/2009
15RNA (Ribonucleic Acid)IBA
01/2022 - 03/2006
15Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 01/2012
14Glucose (Dextrose)FDA LinkGeneric
01/2021 - 11/2006
13Neuroprotective AgentsIBA
07/2022 - 01/2002
12SmokeIBA
05/2022 - 01/2015
12Bu-Fei-Yi-ShenIBA
11/2021 - 10/2015
11DNA (Deoxyribonucleic Acid)IBA
06/2022 - 06/2000
11CollagenIBA
05/2022 - 08/2012
11AntioxidantsIBA
01/2022 - 01/2009
10Interleukin-6 (Interleukin 6)IBA
01/2022 - 08/2012
10Sodium Channels (Sodium Channel)IBA
12/2021 - 08/2006
10Oxygen (Dioxygen)IBA
01/2021 - 12/2012
9Phosphotransferases (Kinase)IBA
07/2022 - 05/2007
9Antiviral Agents (Antivirals)IBA
10/2021 - 01/2013
9Peptides (Polypeptides)IBA
06/2021 - 07/2010
8LigandsIBA
05/2022 - 08/2007
8Paclitaxel (Taxol)FDA LinkGeneric
01/2021 - 04/2010
8Glycoproteins (Glycoprotein)IBA
01/2021 - 01/2013
7Transcription Factors (Transcription Factor)IBA
03/2022 - 05/2010
7NF-kappa B (NF-kB)IBA
03/2021 - 08/2010
7GemcitabineFDA Link
01/2021 - 06/2012
7AcidsIBA
01/2019 - 01/2011
6ErbB Receptors (EGF Receptor)IBA
10/2022 - 07/2014
6LipidsIBA
07/2022 - 04/2013
6Indicators and Reagents (Reagents)IBA
01/2022 - 10/2012
6LipopolysaccharidesIBA
01/2022 - 07/2009
6Dextrans (Dextran)FDA Link
01/2022 - 07/2014
6Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 01/2017
6AntigensIBA
09/2021 - 03/2013
6Attenuated VaccinesIBA
05/2019 - 03/2016
6Doxorubicin (Adriamycin)FDA LinkGeneric
12/2016 - 03/2010
6ORALIT (ORS)IBA
12/2014 - 11/2009

Therapy/Procedure

88Therapeutics
10/2022 - 03/2007
33Drug Therapy (Chemotherapy)
01/2022 - 12/2005
24Immunotherapy
01/2022 - 01/2014
10Radiotherapy
06/2021 - 01/2014
9Chinese Traditional Medicine (Traditional Chinese Medicine)
07/2022 - 11/2012
8Transplantation
11/2020 - 06/2004
7Hematopoietic Stem Cell Transplantation
01/2022 - 12/2016
6Cesarean Section (Caesarean Section)
12/2022 - 10/2013
6Aftercare (After-Treatment)
12/2022 - 06/2007
6Electroacupuncture
01/2022 - 01/2002